Drug Compound, NV-128, Leads To Death Of Ovarian Cancer Cells Resistant To Chemotherapy
Apr 17th 2008Drug InformationCancer
In a discovery that may be useful for maintaining remission in chemo-resistant ovarian cancer, Yale scientists report that pre-clinical studies have shown the drug compound NV-128 can induce the death of ovarian cancer cells by halting the activation of a protein pathway called mTOR. Gil Mor, M.D.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
